PLEASE REVIEW OUR PRIVACY & COOKIES NOTICE

We use cookies to collect and analyze information on site performance and usage and to ensure you can successfully navigate throughout the site.   By clicking the “ACCEPT” button to your right or by clicking on any site content, you agree to the placement of cookies on your computer.  For more information, see our Privacy Policy. 

 
Locations
 
WEBSITES
  • United States (English)
  • International (English)
  • Chinese (中文)
  • French (Français)
  • German (Deutsch)
  • Italian (Italiano)
  • Japanese (日本語)
  • Russian (Русский)
 

Leaving U.S. website

You are now leaving the Haemonetics U.S. website, click 'Yes' to continue or 'No' to stay on the U.S. website.

YesNo
  • Investor Relations
  • LOGIN
    • Haemonetics
    • HSS Client Login
    • Software Download Center
  • REGISTER
  • Home
  • Products
     
    U.S. ProductsView International Products
    Devices
    Blood Center Devices
    • ACP 215
    • MCS+ 8150
    • MCS+ 9000
    • NexSys PCS
    • PCS 2
    Plasma Center Devices
    • NexSys PCS with Persona Technology
    • NexSys PCS with YES Technology
    • NexSys PCS
    • PCS 2
    Surgical and Diagnostic Devices
    • Cell Saver Elite+
    • Cell Saver 5+
    • Cell Saver Elite
    • TEG
    Software
    Hospital Software
    • BloodTrack
    • SafeTrace Tx
    Plasma Center Software
    • DMS
    • NexLynk DMS
    • NextGen
    Services
    Consulting Services
    • Process Improvement
     
  • Solutions
     
    Blood Management Solutions
    • Solutions for Blood Centers
    • Solutions for Hospitals
    • Solutions for Plasma Centers
     
  • Learning Center
     
    Product Training
    • All Products
    • Blood Centers
    • Hospitals
    • Plasma Centers
    Thought Leadership
    • White Papers & Clinical Reviews
    • Reference Lists
    • Poster Abstracts
    Education
       
    • About Haemonetics
       
      Company Background
      • Overview
      • Historical Timeline
      • Leadership Team
      • Scientific Advisory Council

      • Office Locations
      Investor Relations
      • Investor Relations Home
      • Stock Information
      • Earnings
      • Forecasts & Guidance
      Corporate Responsibility
      • Corporate Responsibility at Haemonetics
      Donors Make It Matter
      • Donors Make It Matter Campaign
      News & Events
      • In the News
      • Calendar of Events
      • Publications
      Careers
      • Careers Overview
      • Open Positions
      • Our Global HQ

      Grants

      • Grant Program

       
    • Customer Support

    Leaving U.S. website

    You are now leaving the Haemonetics U.S. website, click 'Yes' to continue or 'No' to stay on the U.S. website.

    YesNo
    • Home
    • Learning Center
    • Thought Leadership
    • Reference Lists
    • TEG Trauma articles
    • Contact Us
    • Print
    • Share

    Trauma articles

    Diagnose acute coagulopathy in trauma (ACOT)

    • Jeger et al. Can RapidTEG Accelerate the Search for Coagulopathies in the Patient with Multiple Injuries? Journal of Trauma 2009; 66: 1253-1257.
    • Kaufman et al. Usefulness of thrombelastography in assessment of trauma patient coagulation. Journal of Trauma 1997; 42; 716-722.

    Early identification of fibrinolysis

    • Kashuk et al. Primary fibrinolyis is integral in the pathogenesis of the acute coagulopathy of trauma. Annals of Surgery Volume 252; 3: September 2010.

    Manage choice of blood products in bleeding patients

    • Gonzalez et al. Coagulation abnormalities in the trauma patient: the role of Thromboelastography. Seminars in Thrombosis and Hemostasis Volume 26; 7: 2010.

    Avoid over-transfusion

    • Kashuk et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Annals of Surgery. Volume 66; 4: April 2010.

    Support activation of massive transfusion protocols

    • Kashuk et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Annals of Surgery. Volume 66; 4: April 2010.

    Diagnose and manage post-traumatic thrombotic conditions (e.g., DVT, PE)

    • Park et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. The Journal of Trauma Volume 67, Number 2, August 2009.
    • Van et al. Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients. Journal of Trauma. 2009;66:1509-1517.

    Manage bleeding and thrombotic complications in acute care surgeries

    • Johansson. Treatment of massively bleeding patients: introducing real-time monitoring, transfusion packages and thrombelastography (TEG). ISBT Science Series (2007) 2, 159-167.

    Differentiate anatomical bleeding from coagulopathy 

    • Johansson. Treatment of massively bleeding patients: introducing real-time monitoring, transfusion packages and thrombelastography (TEG). ISBT Science Series (2007) 2, 159-167.
    • Contact Us
    • Terms of Use
    • Quality
    • Careers
    • Privacy Policy
    • Site Map

    © 2011-2020 Haemonetics Corporation